Name | Equilibrative nucleoside transporter 1 | ||
UniProt ID | S29A1_HUMAN | ||
Gene Name | SLC29A1 | ||
Gene ID | 2030 | ||
Synonyms |
SLC29A1, AUG, ENT1, hENT1
|
||
Sequence |
MTTSHQPQDRYKAVWLIFFMLGLGTLLPWNFFMTATQYFTNRLDMSQNVSLVTAELSKDA
QASAAPAAPLPERNSLSAIFNNVMTLCAMLPLLLFTYLNSFLHQRIPQSVRILGSLVAIL LVFLITAILVKVQLDALPFFVITMIKIVLINSFGAILQGSLFGLAGLLPASYTAPIMSGQ GLAGFFASVAMICAIASGSELSESAFGYFITACAVIILTIICYLGLPRLEFYRYYQQLKL EGPGEQETKLDLISKGEEPRAGKEESGVSVSNSQPTNESHSIKAILKNISVLAFSVCFIF TITIGMFPAVTVEVKSSIAGSSTWERYFIPVSCFLTFNIFDWLGRSLTAVFMWPGKDSRW LPSLVLARLVFVPLLLLCNIKPRRYLTVVFEHDAWFIFFMAAFAFSNGYLASLCMCFGPK KVKPAEAETAGAIMAFFLCLGLALGAVFSFLFRAIV |
||
Pathway Map | MAP LINK | ||
T.C. Number | 2.A.57.1.1 | ||
KEGG ID | hsa2030 | ||
TTD ID | T13491 | ||
Pfam | PF01733; PF07690 |
Pair Name | Sclareolide, Gemcitabine | |||
Phytochemical | Sclareolide | |||
Drug | Gemcitabine | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Regulate Info | Up-regulation | Equilibrative nucleoside transporter 1 | Expression | |
Result | Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer |